Welcome to our dedicated page for Inspire Medical SEC filings (Ticker: INSP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Inspire Medical Systems filings document formal disclosures for a medical technology company commercializing neurostimulation therapy for obstructive sleep apnea. Recent Form 8-K reports furnish quarterly and annual financial results, preliminary revenue information, Regulation FD presentation materials, tax-related events and officer or compensation matters.
Proxy and annual-meeting filings describe director elections, stockholder voting, executive compensation, equity incentive plan authorization and governance provisions, including charter and bylaw matters. These records also disclose common stock award reserves and the governance framework for a company selling Inspire therapy through hospitals and ambulatory surgery centers.
Mead Dana G Jr. reported acquisition or exercise transactions in this Form 4 filing.
Inspire Medical Systems, Inc. director Dana G. Mead Jr. received a grant of 3,562 shares of Common Stock in the form of Restricted Stock Units (RSUs) at no purchase price.
Each RSU represents one share of common stock and will vest on the earlier of the first anniversary of the grant date or immediately before a qualifying Change of Control, as long as he continues serving the company. Following this award, he directly holds 26,213 shares of common stock.
Tansey Casey M reported acquisition or exercise transactions in this Form 4 filing.
Inspire Medical Systems director Casey M. Tansey received a grant of 3,562 shares of common stock as a stock-based award. The award is in the form of Restricted Stock Units, each representing a contingent right to receive one share of common stock, and vests based on continued service, including an anniversary-based condition.
Following this grant, Tansey holds 26,286 shares of common stock directly. In addition, 500 shares are held indirectly by The Kimberly Tansey Irrevocable Trust and 500 shares are held indirectly by The Kylie Tansey Irrevocable Trust.
Curet Myriam reported acquisition or exercise transactions in this Form 4 filing.
Inspire Medical Systems director Myriam Curet received an equity award in the form of restricted stock units. She was granted 3,562 RSUs of common stock at no purchase price, each representing the right to receive one share when vested. The RSUs vest on the earlier of the first anniversary of the grant date or immediately before a Change of Control under the company’s 2018 Incentive Award Plan, if she continues serving the company through that date. Following this award, she directly holds 6,927 shares of Inspire Medical Systems common stock.
Burks Cynthia reported acquisition or exercise transactions in this Form 4 filing.
Inspire Medical Systems director Cynthia Burks received an equity grant in the form of restricted stock units. She was awarded 3,562 RSUs of common stock at no cash cost, increasing her direct holdings to 6,213 shares.
Each RSU represents a right to receive one share of common stock. The RSUs vest on the earlier of the first anniversary of the grant date or immediately before a Change of Control under the company’s 2018 Incentive Award Plan, subject to her continued service.
Inspire Medical Systems director Shelley G. Broader received an equity grant of 3,562 Restricted Stock Units (RSUs) on common stock, with no cash paid per unit. After this award, her direct holdings total 8,471 common shares. Each RSU converts into one share if it vests.
The RSUs vest on the earlier of the first anniversary of the grant date or immediately before a qualifying Change of Control under the company’s 2018 Incentive Award Plan, assuming Broader continues to serve the company through the applicable vesting date.
mcCormick Shawn reported acquisition or exercise transactions in this Form 4 filing.
Inspire Medical Systems director Shawn McCormick reported a new equity grant. He received 3,562 shares of common stock in the form of Restricted Stock Units at no cash cost, increasing his directly held stake to 28,408 shares.
The RSUs vest on the first anniversary of the grant date or immediately before a Change of Control under the company’s 2018 Incentive Award Plan, as long as he continues serving the company. The filing also shows 3,000 shares held indirectly through a trust.
Inspire Medical Systems director Georgia Melenikiotou reported routine equity compensation activity. On April 30, 2026, she received 3,562 Restricted Stock Units (RSUs), each representing one future share of common stock, which vest after one year or immediately before a qualifying change of control if she remains in service.
On May 1, 2026, 50 shares of common stock were withheld by the company to cover tax obligations upon vesting of earlier RSUs, a non-market, tax-withholding disposition rather than an open-market sale. After these transactions, she directly holds 7,985 shares of Inspire Medical Systems common stock.
Inspire Medical Systems Inc ownership report: Vanguard Capital Management reported beneficial ownership of 1,469,703 shares of Common Stock, representing 5.10% of the class. The filing shows sole voting power for 202,965 shares and sole dispositive power for 1,469,703 shares. The statement clarifies these holdings reflect securities managed by Vanguard Capital Management LLC and specified affiliates.